- Home
- SBH vs ODTX Comparison
SBH vs ODTX Comparison
Compare SBH & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | ODTX |
|---|---|---|
| Founded | 1964 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2006 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SBH | ODTX |
|---|---|---|
| Price | $16.03 | $18.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $17.00 | ★ $35.75 |
| AVG Volume (30 Days) | ★ 1.2M | 279.0K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $0.82 | N/A |
| Revenue Next Year | $1.53 | N/A |
| P/E Ratio | $11.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.54 | $15.10 |
| 52 Week High | $17.92 | $29.05 |
Technical Indicators
Market Signals| Indicator | SBH | ODTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 35.96 |
| Support Level | $15.09 | $15.10 |
| Resistance Level | $17.06 | $19.60 |
| Average True Range (ATR) | 0.49 | 1.85 |
| MACD | -0.05 | -0.52 |
| Stochastic Oscillator | 32.04 | 11.74 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About ODTX Odyssey Therapeutics Inc. Common Stock
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.